‘‘(6) The capability to jointly develop a consor-
tium 
of 
providers 
with 
interest 
in 
treating 
neurodegenerative diseases, including Parkinson’s 
Disease, and other movement disorders, at facilities 
without such centers in order to ensure better access 
to state-of-the-art diagnosis, care, and education for 
neurodegenerative disorders throughout the health care 
system. 
‘‘(7) The capability to develop a national reposi-
tory for the collection of data on health services deliv-
ered to veterans seeking care for neurodegenerative 
diseases, including Parkinson’s Disease, and other 
movement disorders in the health care system. 
‘‘(d)(1) The Under Secretary for Health shall establish 
a panel to assess the scientific and clinical merit of pro-
posals that are submitted to the Secretary for the establish-
ment of new centers under this section. 
‘‘(2)(A) The membership of the panel shall consist of 
experts in neurodegenerative diseases, including Parkin-
son’s Disease, and other movement disorders. 
‘‘(B) Members of the panel shall serve as consultants 
to the Department for a period of no longer than two years 
except in the case of panelists asked to serve on the initial 
panel as specified in subparagraph (C).
‘‘(C) In order to ensure panel continuity, half of the 
members of the first panel shall be appointed for a period 
of three years and half for a period of two years. 
‘‘(3) The panel shall review each proposal submitted 
to the panel by the Under Secretary and shall submit its 
views on the relative scientific and clinical merit of each 
such proposal to the Under Secretary. 
‘‘(4) The panel shall not be subject to the Federal Advi-
sory Committee Act. 
‘‘(e) Before providing funds for the operation of any 
such center at a health-care facility other than a health-
care facility designated under subsection (b)(1), the Sec-
retary shall assure that the center at each facility des-
ignated under such subsection is receiving adequate funding 
to enable such center to function effectively in the areas of 
Parkinson’s Disease research, education, and clinical ac-
tivities. 
‘‘(f) There are authorized to be appropriated such sums 
as may be necessary for the support of the research and 
education activities of the centers established pursuant to 
subsection (a). The Under Secretary for Health shall allo-
cate to such centers from other funds appropriated generally 
for the Department medical services account and medical 
and prosthetics research account, as appropriate, such
amounts as the Under Secretary for Health determines ap-
propriate. 
‘‘(g) Activities of clinical and scientific investigation 
at each center established under subsection (a) shall be eligi-
ble to compete for the award of funding from funds appro-
priated for the Department medical and prosthetics re-
search account and shall receive priority in the award of 
funding from such account insofar as funds are awarded 
to projects for research in Parkinson’s disease and other 
movement disorders.’’. 
(2) CLERICAL AMENDMENT.—The table of sec-
tions at the beginning of such chapter is amended by 
inserting after the item relating to section 7328 the 
following new item:
‘‘7329. Parkinson’s Disease research, education, and clinical centers.’’.
(b) EFFECTIVE DATE.—Section 7329 of title 38, 
United States Code, as added by subsection (a), shall take 
effect on October 1, 2005.